Dopaminergic medications in Parkinson's disease (PD) are usually associated with the development of both levodopa-induced dyskinesias (LID) and impulse control and repetitive behavior disorders (ICRB).
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation
Simoni, Simone;Paoletti, Federico Paolini;Eusebi, Paolo;Cappelletti, Giulia;Filidei, Marta;Brahimi, Elona;Nigro, Pasquale;Santangelo, Valerio;Parnetti, Lucilla;Calabresi, Paolo;Tambasco, Nicola
2020
Abstract
Dopaminergic medications in Parkinson's disease (PD) are usually associated with the development of both levodopa-induced dyskinesias (LID) and impulse control and repetitive behavior disorders (ICRB).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
